Gastrointestinal Remedies - US - April 2012
US $4,395.00 (Excl.Tax)Excl. Tax Buy Now
Sales of gastrointestinal (GI) remedies grew considerably in 2009, in part because of strong demand for over-the-counter (OTC) versions of prescription remedies such as Prilosec OTC. This growth, however, decelerated in 2010 and 2011. While significant opportunities exist in the category, it is evident that at this point in history brands must work harder than ever to garner customer loyalty and differentiate if they want to succeed in this challenging marketplace. This is especially true for national brands, as they have been losing share to private label in recent years.
In order to provide facts and insights that can help companies succeed in this challenging marketplace, Mintel has published this report which addresses the following questions:
This report will give you a complete 360-degree view of your market. Not only is it rooted in robust proprietary and high-quality third-party data, but our industry experts put that data into context and you’ll quickly understand:
What They Want. Why They Want It.
Who’s Winning. How To Stay Ahead.
Size, Segments, Shares And Forecasts: How It All Adds Up.
New Ideas. New Products. New Potential.
Where The White Space Is. How To Make It Yours.
What’s Shaping Demand – Today And Tomorrow.